Triple-Threat attack on spreading head & neck cancer
NCT ID NCT05524168
Summary
This study is testing a three-part treatment for nasopharyngeal cancer that has spread to a few other areas in the body. It combines a type of immunotherapy (PD-1 antibody), chemotherapy, and very precise, high-dose radiation (SBRT). The goal is to see if this combination can better control the cancer and extend the time patients live without it getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510060, China
Conditions
Explore the condition pages connected to this study.